4 completed, 2 unknown. 3 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 3 | Unknown 2, Completed 1 |
Follow miravirsen: new trials by email Literature Review of miravirsen trials Research Report on miravirsen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Miravirsen in Combination With Telaprevir and Ribavirin in Null Responder to Pegylated-Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C Virus Infection Miravirsen, Telaprevir, Ribavirin - Hepatitis C, Chronic | Phase 2 | Unknown | Santaris Pharma A/S | 20 | 2013-06-01 | 2014-11-18 |
| Miravirsen Study in Null Responder to Pegylated Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C Miravirsen sodium - Hepatitis C | Phase 2 | Unknown | Santaris Pharma A/S | 10 | 2012-11-01 | 2014-01-06 |
| Drug Interaction Study to Assess the Effect of Co-Administered Miravirsen and Telaprevir in Healthy Subjects Miravirsen sodium, Telaprevir - Hepatitis C, Chronic Hepatitis C | Phase 1 | Completed | Santaris Pharma A/S | 5 | 2012-06-01 | 2012-11-12 |
| Multiple Ascending Dose Study of Miravirsen in Treatment-Naïve Chronic Hepatitis C Subjects miravirsen, saline - Hepatitis C | Phase 2 | Completed | Santaris Pharma A/S | 38 | 2010-09-01 | 2012-01-31 |
| SPC3649 Multiple Dose Study in Healthy Volunteers SPC3649, saline - Hepatitis C | Phase 1 | Completed | Santaris Pharma A/S | 30 | 2009-09-01 | 2011-10-05 |
| Safety Study of SPC3649 in Healthy Men SPC3649 - Hepatitis C | Phase 1 | Completed | Santaris Pharma A/S | 64 | 2008-05-01 | 2009-09-18 |
Hepatitis C (5) · Hepatitis C, Chronic (3)
Puerto Rico (3) · United States (3) · Netherlands (2) · Denmark (1) · Germany (1) · Poland (1) · Slovakia (1)
Maribel Rodriguez-Torres, MD (1) · Michael Hodges, MD (1) · Paul Rice, MD (1) · Salah Hadi, MD,MSc (1) · Stefan Zeuzem, MD (1)